SYK and cancer: Even though lots of studies have indicated that SYK negatively regulates cell proliferation and migration in cancer cells, lots of SYK inhibitors are considered as promising anti-cancer drugs in both clinical studies and pre-clinical studies [1, 19, 57, 58].